Clinical trial
Oxygenated Perfusion for Enhanced Renal Function in Donation After Circulatory Death (DCD) Kidney Transplants (OxyPERF) - A National Swedish Randomized Controlled Trial
NCT07779187 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oxygenated Perfusion for Enhanced Renal Function in Donation After Circulatory Death (DCD) Kidney Transplants (OxyPERF) - A National Swedish Randomized Controlled Trial
- Lead sponsor
- Karolinska University Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2027
- Completion date
- December 31, 2030
- Enrollment
- 214 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
dcd kidney, kidney transplant